CSBR Historical PE Ratio image   This CSBR PE ratio history page last updated 9/12/2022
CSBR Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q1 2023
9/8/2022
7.260.000.00NA
Q4 2022
7/21/2022
8.00-0.02-0.08NA
Q3 2022
3/15/2022
7.590.070.2827.1
Q2 2022
12/13/2021
8.040.020.08100.5
Q1 2022
9/13/2021
10.100.010.04252.5
Q4 2021
7/22/2021
10.32-0.04-0.16NA
Q3 2021
3/11/2021
11.000.050.2055.0
Q2 2021
12/14/2020
11.550.000.00NA
Q1 2021
9/14/2020
7.580.010.04189.5
Q4 2020
7/27/2020
8.95-0.14-0.56NA
Q3 2020
3/12/2020
4.190.030.1234.9
Q2 2020
12/16/2019
7.610.020.0895.1
Q1 2020
9/16/2019
6.90-0.05-0.20NA
Q4 2019
7/15/2019
8.99-0.01-0.04NA
Q3 2019
3/18/2019
10.610.000.00NA
Q2 2019
12/17/2018
9.550.030.1279.6
Q1 2019
9/13/2018
8.480.050.2042.4
Q4 2018
7/26/2018
9.18-0.04-0.16NA
Q3 2018
3/15/2018
4.070.000.00NA
Q2 2018
12/7/2017
3.790.000.00NA
Q1 2018
9/14/2017
3.22-0.05-0.20NA
Q4 2017
7/27/2017
2.51-0.15-0.60NA
Q3 2017
3/16/2017
3.04-0.11-0.44NA
Q2 2017
11/29/2016
1.910.000.00NA
Q1 2017
9/9/2016
1.76-0.15-0.60NA
Q4 2016
7/28/2016
2.00-0.24-0.96NA
Q3 2016
3/15/2016
3.50-0.21-0.84NA
Q2 2016
12/14/2015
3.62-0.24-0.96NA
Q1 2016
9/10/2015
6.80-0.24-0.96NA
Q4 2015
7/24/2015
6.00-0.02-0.08NA
Q3 2015
5/22/2015
6.96-0.49-1.96NA
CSBR PE History Chart
PeriodPriceAdj. EPSTTMPE
Q1 2023
9/8/2022
7.260.000.07103.7
Q4 2022
7/21/2022
8.00-0.020.08100.0
Q3 2022
3/15/2022
7.590.070.06126.5
Q2 2022
12/13/2021
8.040.020.04201.0
Q1 2022
9/13/2021
10.100.010.02>500
Q4 2021
7/22/2021
10.32-0.040.02>500
Q3 2021
3/11/2021
11.000.05-0.08NA
Q2 2021
12/14/2020
11.550.00-0.10NA
Q1 2021
9/14/2020
7.580.01-0.08NA
Q4 2020
7/27/2020
8.95-0.14-0.14NA
Q3 2020
3/12/2020
4.190.03-0.01NA
Q2 2020
12/16/2019
7.610.02-0.04NA
Q1 2020
9/16/2019
6.90-0.05-0.03NA
Q4 2019
7/15/2019
8.99-0.010.07128.4
Q3 2019
3/18/2019
10.610.000.04265.2
Q2 2019
12/17/2018
9.550.030.04238.8
Q1 2019
9/13/2018
8.480.050.01>500
Q4 2018
7/26/2018
9.18-0.04-0.09NA
Q3 2018
3/15/2018
4.070.00-0.20NA
Q2 2018
12/7/2017
3.790.00-0.31NA
Q1 2018
9/14/2017
3.22-0.05-0.31NA
Q4 2017
7/27/2017
2.51-0.15-0.41NA
Q3 2017
3/16/2017
3.04-0.11-0.50NA
Q2 2017
11/29/2016
1.910.00-0.60NA
Q1 2017
9/9/2016
1.76-0.15-0.84NA
Q4 2016
7/28/2016
2.00-0.24-0.93NA
Q3 2016
3/15/2016
3.50-0.21-0.71NA
Q2 2016
12/14/2015
3.62-0.24-0.99NA
Q1 2016
9/10/2015
6.80-0.24NANA
Q4 2015
7/24/2015
6.00-0.02NANA
Q3 2015
5/22/2015
6.96-0.49NANA
Quotes delayed 20 minutes

Email EnvelopeFree CSBR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Champions Oncology (CSBR) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

CSII PE Ratio History
CSTL PE Ratio History
CSU PE Ratio History
CTIC PE Ratio History
CTKB PE Ratio History
CTLT PE Ratio History
CTMX PE Ratio History
CTSO PE Ratio History
CTXR PE Ratio History
CUE PE Ratio History
How should the CSBR historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Champions Oncology. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this CSBR Historical PE Ratio page.

What is the average historical PE for CSBR based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The CSBR historical PE ratio using the annualized quarterly earnings method works out to 97.4.

What is the average historical PE for CSBR based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The CSBR historical PE ratio using the TTM earnings method works out to 166.2.

What is the average historical PE for CSBR based on median TTM earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the median earnings over the trailing twelve months and annualize that median result in the calculation?

✔️Accepted answer: The CSBR historical PE ratio using the annualized median TTM earnings method works out to 0.04.

On this page we presented the CSBR Historical PE Ratio information for Champions Oncology' stock. The average CSBR historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 97.4. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CSBR historical PE based on this TTM earnings result method is 166.2. Note: any PE calculations resulting in a value exceeding 500 were discarded as not meaningful. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this CSBR historical PE result, against the recent PE: when this page was posted on 9/9/2022, the most recent closing price for CSBR had been 7.41, and the most recent quarterly earnings result, annualized, was 0.28. Meanwhile, the most recent TTM earnings summed to 0.07. From these numbers, we calculate the recent CSBR PE on 9/9/2022 based on annualized quarterly EPS was 26.5. Based on CSBR's history, that recent PE is low relative to the historical average, with the recent PE 72.8% lower than the historical average PE across our data set for Champions Oncology. Looking at the recent CSBR PE on 9/9/2022 based on TTM EPS, we calculate the ratio at 105.9. Based on CSBR's history, that recent PE is low relative to the historical average, with the recent PE 36.3% lower than the average PE across our Champions Oncology data set with TTM EPS used in the calculation at each period.

Another interesting CSBR historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for CSBR, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for CSBR, we start with the past four EPS numbers and we first sort them from lowest to highest: -0.02, 0.00, 0.02, and 0.07. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.00 and 0.02 — which gives us the median of 0.01. Basically the way to think about this 0.01 number is this: for the trailing four earnings reports, 0.01 marks the "middle ground" number where CSBR has reported a value higher than 0.01 half the time, and has reported a value lower than 0.01 half the time. Annualizing that median value then gets us to 0.04/share, which we use as the denominator in our next PE calculation. With 7.41 as the numerator (as of 9/9/2022), the calculation is then 7.41 / 0.04 = 185.2 as the CSBR PE ratio as of 9/9/2022, based on that annualized median value we calculated.

For self directed investors doing their due diligence on CSBR or any other given stock, valuation analysis for CSBR can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Champions Oncology PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CSBR. Thanks for visiting, and the next time you need to research CSBR Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: UTI shares outstanding history, ETFs Holding HTBI, Funds Holding LIVX.

 

CSBR Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.